What drugs does CORSTASIS THERAP make?

CORSTASIS THERAP has 1 FDA-approved drugs including ENBUMYST.

What therapeutic areas does CORSTASIS THERAP focus on?

CORSTASIS THERAP focuses primarily on Cardiovascular and Gastroenterology.

Data updated: Mar 10, 2026

CORSTASIS THERAP

CardiovascularGastroenterology

Pharma

CORSTASIS THERAP is a pharmaceutical company focused on Cardiovascular, Gastroenterology. Key products include ENBUMYST.

2025

Since

Drugs

Trials

Approved (2yr)

Key Drugs

Recent Activity

ENBUMYST 2025-09-12

Type 3 - New Dosage Form

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 50%

1 drugs

Gastroenterology 50%

1 drugs

Pipeline Strength ProEarly access

Competitors ProEarly access

BAUSCH specialty

Cardiovascular, Gastroenterology

APOTHECON specialty

Cardiovascular, Gastroenterology

VALIDUS PHARMS specialty

Cardiovascular, Gastroenterology

WAYLIS THERAP big-pharma

Cardiovascular, Gastroenterology

WARNER CHILCOTT LLC specialty

Cardiovascular, Gastroenterology

CORSTASIS THERAP

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (1)

Active (1)

Discontinued (0)

Company Info